Andere talen Mydecine Innovations Group Inc. Deutsche Boerse AG

Aandelen

0NF0

CA62849F2008

Beurs gesloten - Deutsche Boerse AG Andere beurzen 08:05:18 31-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,01 ^EUR	-4,76%		-.--%	-23,08%

23/02	Mydecine Innovations rondt gedeeltelijke schuldregeling af	MT
02/02	Mydecine Innovations Group Inc kondigt aan dat Neil Stevenson-Moore ontslag heeft genomen als bestuurder	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Mydecine Innovations Closes Partial Debt Settlement	23/02
Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director	02/02
Mydecine Innovations Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	18/11
Mydecine Innovations Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15-08-23
Mydecine Innovations Group Inc. Appoints John Ross as Corporate Secretary	21-07-23
Mydecine Innovations Group Appoints Todd Heinzl to the Board of Directors	30-05-23
Mydecine Innovations Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	16-05-23
Mydecine Innovations Group Inc. Reports Positive Preclinical Results on the MYCO-006 Series of its Short-Acting Emp Analogues	24-04-23
Mydecine Innovations Group Inc. Auditor Raises 'Going Concern' Doubt	31-03-23
Mydecine Innovations Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	31-03-23
Pangenomic Health Inc. completed the acquisition of Mindleap Health Inc. from Mydecine Innovations Group Inc. (OTCPK:MYCO.F).	09-12-22
Mydecine Innovations Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14-11-22
Mydecine Innovations Group Inc. Announces Board Changes	29-08-22
Mydecine Innovations Group Inc. Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting Mdma Analogs	29-08-22
Mydecine Innovations Group Inc. Announces Board Changes	19-08-22
Mydecine Innovations Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16-08-22
Mydecine Innovations Group Inc. Announces Resignation of Directors	12-08-22
Mydecine Files Full Patent Application Covering Myco-006 Family of Novel Short-Acting Mdma Analogs	19-07-22
Mydecine Innovations Group Announces U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation	17-06-22
Mydecine Innovations Group Inc. Announces Board Changes	09-06-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Mydecine Innovations Group Inc. Deutsche Boerse AG

Aandelen

0NF0

CA62849F2008

Andere talen

Filters